Researchers from The University of Toledo studied the impact of blue light — which comes from the sun as well as digital devices — on our eyes.
Biotech
FDA Approves Hydrus Microstent for Glaucoma Surgery
The US Food and Drug Administration (FDA) has approved the Hydrus Microstent, a device used for microinvasive glaucoma surgery (MIGS) in patients with mild to moderate primary open-angle glaucoma, in conjunction with cataract surgery.
Research Reveals Autoimmune Disease as the Cause of Glaucoma
A breakthrough from researchers from MIT and Massachusetts Eye and Ear has revealed that the body’s own immune cells may be the culprit behind the slow retinal deterioration associated with glaucoma.
You must be logged in to post a comment.